This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

InGel Therapeutics

Profile

InGel Tx is a Harvard cell-based therapy biotech focusing on novel neuroprotective mechanism in the eye to stop and repair retinal degeneration. Our core technology combines expertise across stem cell biology, genetics and biomaterials, with some of the best scientific founders and advisors such as Professor Michael Young and Professor Connie Cepko from Harvard Medical School.